Eber Marcel Mendoza Osorio

Eber Marcel Mendoza Osorio

Auto-generated profile, based on publicly available information

Eber Marcel Mendoza Osorio

Nuevo Hospital Civil de Guadalajara Juan I. Menchaca

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2026 in International Science Journal
Verified
Journal Article
Open access
PDF file
MHMaría Fernanda Carbajal Hernández
María Fernanda Carbajal Hernández
KCKatherine Paola Hidalgo Chuquimarca
Katherine Paola Hidalgo Chuquimarca
INIsabel Huerta Nagore
Isabel Huerta Nagore
MVMario Daniel Vengoechea Visbal
Mario Daniel Vengoechea Visbal
JMJosselyn Ivett Yangari Medina
Josselyn Ivett Yangari Medina
ERErika Romina Cuenca Riascos
Erika Romina Cuenca Riascos
Short bowel syndrome (SBS) represents a complex consequence of extensive intestinal resection, characterized by impaired nutrient absorption, fluid and electrolyte disturbances, and variable degrees of intestinal failure requiring prolonged nutritional support. This narrative review aimed to analyze the physiological mechanisms of gastrointestinal adaptation and evaluate the clinical relevance of nutritional rehabilitation, pharmacological treatment, and surgical reconstruction in patients with SBS, incorporating international evidence and Latin American clinical experience. A descriptive and analytical synthesis of 20 scientific publications, including international guidelines, randomized controlled trials, systematic reviews, and observational studies published between 2014 and 2024, was conducted. The findings identified residual intestinal anatomy, preservation of ileal and colonic continuity, and adaptive capacity as major determinants of functional recovery. Nutritional rehabilitation emerged as the foundation of treatment, integrating parenteral support with progressive enteral stimulation and individualized dietary strategies. Pharmacological therapy with teduglutide demonstrated significant benefits, with 63% of treated patients achieving a predefined reduction in parenteral support requirements compared with 30% receiving placebo. Surgical reconstruction through serial transverse enteroplasty (STEP) and longitudinal intestinal lengthening and tailoring (LILT) was associated with reported parenteral nutrition independence rates of 46% and 52%, respectively, although methodological heterogeneity prevented definitive comparisons. Latin American evidence, particularly the RESTORE Registry, documented differences in rehabilitation outcomes between adult and pediatric populations, emphasizing the complexity of regional clinical management. Overall, the evidence indicates that intestinal rehabilitation requires individualized multidisciplinary strategies integrating gastrointestinal physiology, nutritional support, pharmacological interventions, and reconstructive surgery when appropriate. Further prospective multicenter investigations are necessary to standardize clinical outcomes, identify predictors of nutritional autonomy, and improve long-term functional recovery and quality of life.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
VCVicente Treviño Caballero
Vicente Treviño Caballero
BABricey Daniela Fonseca Aldana
Bricey Daniela Fonseca Aldana
DPDidier Leonidad Diaz Parra
Didier Leonidad Diaz Parra
ACAmbar Karolina Cedeño Cedeño
Ambar Karolina Cedeño Cedeño
EOEber Marcel Mendoza Osorio
Eber Marcel Mendoza Osorio
DGDalia Arizbeth Escobar Gómez
Dalia Arizbeth Escobar Gómez
Major gastrointestinal surgery remains associated with considerable postoperative morbidity, delayed functional recovery, and prolonged hospitalization, highlighting the need for integrated perioperative strategies. This narrative review aimed to analyze the clinical relevance of multimodal prehabilitation and Enhanced Recovery After Surgery (ERAS) protocols, emphasizing perioperative nutritional optimization, multimodal analgesia, and gastrointestinal functional recovery. A descriptive, analytical, and integrative approach was adopted to examine 20 scientific publications, including randomized controlled trials, systematic reviews, meta-analyses, and international clinical guidelines, with particular consideration of their applicability to Latin American healthcare settings. The reviewed evidence demonstrated heterogeneous but clinically relevant benefits associated with multimodal prehabilitation, including reductions in selected postoperative complications and improvements in functional recovery. Preoperative oral nutritional supplementation was associated with fewer infectious complications, whereas carbohydrate loading and early oral feeding demonstrated favorable outcomes regarding gastrointestinal recovery and hospitalization duration. Multimodal analgesic interventions, particularly intravenous lidocaine and transversus abdominis plane blocks, were associated with reduced early postoperative pain and opioid consumption. Improvements in gastrointestinal recovery were reflected in shorter times to bowel sounds, first flatus, and first defecation, although these findings did not consistently establish reductions in clinically defined postoperative ileus. Variability in patient characteristics, surgical procedures, intervention protocols, and institutional resources limited direct comparisons between studies. The findings support a coordinated, multidisciplinary, and patient-centered approach to perioperative management. Further research is necessary to determine optimal intervention combinations, standardize recovery outcomes, and evaluate the effectiveness and feasibility of integrated ERAS pathways across diverse healthcare systems, particularly in Latin America.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
LHLuis Alberto Erosa-De Haro
Luis Alberto Erosa-De Haro
CFCamilo José Izquierdo Flores
Camilo José Izquierdo Flores
EOEber Marcel Mendoza Osorio
Eber Marcel Mendoza Osorio
JSJuan José Vergara Serpa
Juan José Vergara Serpa
AMAlvaro Enrique Marroquin Murcia
Alvaro Enrique Marroquin Murcia
TSTatiana Isabel Panqueva Sánchez
Tatiana Isabel Panqueva Sánchez
Neurodevelopmental disorders represent a heterogeneous group of conditions characterized by alterations in cognitive, behavioral, motor, and neurological development, frequently associated with complex genetic mechanisms. Among these, de novo genetic variants have emerged as major contributors to severe developmental phenotypes, including intellectual disability, global developmental delay, autism spectrum disorder, and developmental epileptic encephalopathies. This review examines the molecular contribution of newly arising genetic variants, the diagnostic performance of next-generation sequencing technologies, genotype–phenotype correlations, and the clinical implications of early molecular identification. A structured narrative review was developed using 20 foundational and contemporary scientific publications, complemented by recent evidence concerning clinical utility, with particular attention to international investigations and Latin American contributions. The reviewed evidence indicates that pathogenic de novo coding variants account for an estimated 42% of severe developmental disorders in a major genomic cohort, while exome sequencing demonstrates an overall diagnostic yield of approximately 36% across neurodevelopmental populations. Evidence from Brazil further illustrates the relevance of newly arising variants in genetically heterogeneous pediatric cohorts. Molecular findings reveal convergence among genes involved in chromatin remodeling, transcriptional regulation, synaptic organization, and neuronal excitability, highlighting the complexity of genotype–phenotype relationships. Furthermore, positive genomic diagnoses may contribute to modifications in clinical management, although improvements in long-term developmental outcomes remain insufficiently established. Persistent challenges include uncertain variant classification, incomplete molecular characterization, unequal population representation, and limited access to genomic technologies. The integration of genomic sequencing, comprehensive clinical phenotyping, genetic counseling, and multidisciplinary pediatric care constitutes a fundamental strategy for improving etiological diagnosis and supporting individualized management. Expanded international collaboration and longitudinal research are necessary to strengthen clinical translation and equitable access to precision genomic medicine.